Tesetaxel

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTesetaxel
Drug Alias Name替司他赛Tesetaxelum特瑟紫杉醇DJ-927
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionApoptosis stimulantsTubulin inhibitorsMitosis inhibitors
TargetsTubulin
Therapy Area/IndicationsMetastatic breast cancerSolid tumoursProstatic Neoplasms +[11] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumCanada +[21] 
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesGenta Incorporated
Inactive CompaniesOdonate Therapeutics IncThe University Of Texas MD Anderson Cancer CenterDaiichi Sankyo Co Ltd
Active IndicationsBreast Neoplasms
Inactive IndicationsMetastatic breast cancerSolid tumoursProstatic Neoplasms +[10] 

Other Information

ATC CodeN/A
Related LinksWikipedia